198
Views
45
CrossRef citations to date
0
Altmetric
Original Article

Formulation and Evaluation of Ciprofloxacin Hydrochloride Soluble Ocular Drug Insert

&
Pages 469-475 | Received 01 Aug 2007, Accepted 24 Feb 2008, Published online: 02 Jul 2009

REFERENCES

  • Hecht G. Ophthalmic preparations. Remington: The Science and Practice of Pharmacy, A F Gennaro. Mack Publishing, Easton, PA 1995; vol. II: 1563
  • Maurice D M. Kinetics of topically applied drugs. Ophthalmic Drug Delivery, Biopharmaceutical, Technological and Clinical Aspects, M F Saettone, P Bucci, P Speiser. Liviana Press, PadovaItaly 1987; vol. II: 19–26, Fidia Research Series
  • Grass G M, Robinson J R. Relationship of chemical structure to corneal penetration and influence of low viscosity solution on ocular bioavailability. J Pharm Sci 1984; 73: 1021–1027
  • Saettone M F, Giaccinni B, Ravecca S, La Marca F, Tota G. Polymers effect on ocular bioavailability. The influence of different liquid vehicles on mydriatic response of tropicamide in humans and in rabbits. Int J Pharm 1984; 20: 187–202
  • Gurtler F, Gurny R. Patent literature review of ophthalmic inserts. Drug Dev Ind Pharm 1995; 21: 1–18
  • Lee V HL. Review: New directions in optimization of ocular drug delivery. J Ocular Pharmacol 1990; 6: 157–164
  • Chien Y W. Ocular controlled release drug administration. Novel Drug Delivery Systems, J Swarbrick. Marcel Dekker, New York 1982; 13–48
  • Chiou G CY, Watanabe K. Drug delivery to the eye. Pharm Ther 1982; 17: 269–278
  • Mikkelson T J. Ophthalmic drug delivery. Pharm Technol 1984; 91: 89–98
  • Shell J W. New ophthalmic drug delivery systems. Ophthalmic Drug Delivery Systems, J R Robinson. American Pharmaceutical Association, Washington, DC 1980; 145–157
  • Lee V HL, Robinson J R. Review: Topical ocular drug delivery: Recent developments and future challenges. J Ocular Pharmacol 1986; 2: 67–108
  • Salminen L. Pilocarpine inserts: Experimental and clinical experiences. Ophthalmic Drug Delivery, Biopharmaceutical, Technological, and Clinical Aspects, M F Saettone, P Bucci, P Speiser. Liviana Press, PadovaItaly 1987; 161–170, Fidia Research Series
  • Richardson K T. Ocular microtherapy: Membrane controlled drug delivery. Arch Ophthalmol 1975; 93: 74–86
  • Buri P. Voie Ocularie. Formes Pharmaceutiques Nouvelles., P Buri, F Puisieux, E Doelker, J P Benoit. Lavoisier, Paris 1985; 411–438
  • Bawa G. Ocular inserts. Ophthalmic Drug Delivery Systems, A K Mitra. Marcel Dekker, New York 1993; 223–259
  • Saettone M F. Solid polymeric inserts/disks as drug delivery devices. Biopharmaceutics of Ocular Drug Delivery, P Edmon. CRC Press, Boca Raton, FL 1993; 61–79
  • Chambers H F. Sulfonamides, trimethoprim, and quinolones. Basic and Clinical Pharmacology, B G Katzung. McGraw-Hill, New York 2001; 799
  • Saettone M F, Saleminen L. Ocular inserts for topical delivery. Adv Drug Deliv Rev 1995; 16: 95–106
  • Jayaprakash S, James C C, Maria Gerald Rajan N S, Saisivam S S, Nagarajan M. Design and evaluation of ketorolac tromethamine ocuserts. Ind J Pharm Sci 2000; 62: 334–338
  • Aryata M, Sfeir T. Traitement de la secheresse oculaire par implants solubles. Bull Soc Fr Ophthalmol 1981; 92: 134
  • Mundada A S, Shrikhande B K. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride. Drug Dev Ind Pharm 2006; 32: 443–448
  • Pharmacopoeia of India. 4th edition. Controller of publication, Ministry of Health and Family Welfare, Government of India, New Delhi 1996; vol. I: 190
  • Ali A, Sharma S N. Fabrication of flow through apparatus for in vitro determination of drugs from ophthalmic preparations. Indian Drugs 1991; 29: 157
  • Dhanaraju M D, Sivakumar V R, Subhashree R, Bhaskar K. Bioadhesive ocusert matrix for ophthalmic administration of ciprofloxacin hydrochloride. Indian Drugs 2002; 39: 222–224
  • Saisivam S, Manikandav R VM, Nagarajan M. Design and evaluation of ciprofloxacin hydrochloride ocuserts. Ind J Pharm Sci 1999; 61: 34–38
  • Aquil M. Advances in ophthalmic drug delivery systems. 2005; 1–14, www.pharmainfo.net Part II
  • Chien Y W. Ocular drug delivery and delivery systems. Novel Drug Delivery Systems. Marcel Dekker, New York 1993; 269–301
  • Robinson J C. Ocular anatomy and physiology relevant to ocular drug delivery. Ophthalmic Drug Delivery, A K Mitra. Marcel Dekker, New York 1993; 32
  • Draize J H, Woodward G, Calvery H O. Methods for the study of irritation and toxicity of substance applied topically to the skin and mucous membrane. J Pharmacol Exp Ther 1944; 82: 377–390
  • Kurkuri M D, Kulkarni A R, Karidurganavar M Y, Aminabhavi T M. In vitro release study of verapamil hydrochloride through sodium alginate interpenetrating monolithic membranes. Drug Dev Ind Pharm 2001; 27: 1107–1114
  • Dandagi P M, Manvi F V, Patil M B, Mastiholimath V S, Rathod R. Development and evaluation of ocular films of cromolyn sodium. Ind J Pharm Sci 2004; 66: 309–312

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.